000			01523nam a2200181Ia 4500
003			MX-MdCICY
005			20250625124706.0
040			_cCICY
090			_aB-7726
245	1	0	_aGiardiasis: Recent Progress in Chemotherapy and Drug Development
490	0		_vCurrent Pharmaceutical Design, 9(11), p.841-855, 2003
520	3		_aGiardiasis is a protozoal disease infecting 200 million people throughout the world. Giardiasis is widespread primarily in developing countries. Infections are correlated with poor hygienic conditions, poor water quality control, and overcrowding. There are very few therapeutics currently available, and drug development to treat giardiasis is hampered mainly by socioeconomic obstacles. This article presents the history of antigiardial chemotherapy and current state of therapeutic availability along with the future prospectus of development of antigiardial agents. In addition to accumulated knowledge about the previous and current antigiardial drugs, advanced technologies including computer-aided drug design and combinatorial synthetic chemistry, as well as high throughput screening techniques, accelerate understanding of the disease and further research toward a suitable antigiardial agent.
700	1	2	_aMineno, T.
700	1	2	_aAvery, M.A.
856	4	0	_uhttps://drive.google.com/file/d/1c2GmKfSPftDDPX8fEKfn8OOhOwNM6aJA/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx
942			_2Loc _cREF1
008			250602s9999 xx |||||s2 |||| ||und|d
999			_c42049 _d42049